2022 AUA preview: Dr. Pearlman on top research in sexual dysfunction and infertility
Amy M. Pearlman, MD, highlights 6 studies in sexual dysfunction and infertility being presented at the 2022 American Urological Association Annual Meeting.
EP: 1.2022 AUA preview: Dr. Pearlman on top research in sexual dysfunction and infertility
EP: 2.2022 AUA preview: Dr. Krambeck on top research in BPH and urinary stones
EP: 3.2022 AUA preview: Dr. Almassi on top research in bladder cancer
EP: 4.2022 AUA preview: Dr. Schwen on top research in prostate cancer
In this video, Amy M. Pearlman, MD, discusses 6 studies in sexual dysfunction and infertility being presented at the 2022 American Urological Association Annual Meeting. Pearlman is a clinical assistant professor and Men's Health Program Director at the University of Iowa, Iowa City.
The following 6 abstracts are previewed:
LBA02-09 (Hallak, et al): Intracellular SARS-COV-2 Found In The Spermatozoa Of Convalescent Men With Negative Pcr Semen Samples Revealed By Electron Microscopy
LBA02-11 (Shechter, et al): Novel On-Demand Treatment For Lifelong Premature Ejaculation Using Transcutaneous Perineal Mini-Patch Stimulator
PD09-05 (Marinaro, et al): Use of Fresh Ejaculated Semen Samples on the Day of Planned mTESE in Men with "Azoospermia"
MP21-02 (Flores, et al): Predictors of Corporo-Venocclusive Dysfunction (CVOD) in Men With Bilateral Nerve-Sparing Radical Prostatectomy (RP)
PD23-01 (Tyler, et al): Improved Peyronie's Disease Curvature Outcomes Using a More Aggressive Collagenase Technique
MP34-02 (Able, et al): Opioid Prescribing Following Male Infertility Surgery is Associated with Persistent Opioid Use - Analysis of a U.S. Claims Database
UGN-102 reaches nearly 80% complete response rate in low-grade intermediate-risk NMIBC
November 30th 2023Primary chemoablative therapy with the mitomycin-containing reverse thermal gel UGN-102 induced complete responses in nearly 4 out of 5 patients with low-grade intermediate-risk non–muscle-invasive bladder cancer.
